As shown in Figure 4, median serum Dkk-1 levels were significantly higher in women with breast cancer and bone metastases compared to women with breast cancer in complete remission (P=0.016), women with breast cancer and metastases at non-bone sites (P<0.0001) and healthy women (P=0.047). This evidence concerns the gene DKK1 and breast cancer.